Physician profile
Edgar A Abbes
NPI 1568526689
$4,615.17
in general payments reported to CMS, 2019-2025
13 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $202 · 2021: $581 · 2022: $431 · 2023: $909 · 2024: $629 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,646.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,471.15 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $770.22 | 2019-2020 | |
| Biotissue Holdings INC. | $724.93 | 2025 | |
| Integra Lifesciences Corporation | $690.21 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Innovation Technologies INC | $156.91 | 2025 | Irrisept |
| Linvatec Corporation | $151.07 | 2024 | Biobrace 23mm |
| Smith+Nephew, INC. | $140.59 | 2019-2022 | |
| Depuy Synthes Sales INC. | $125.78 | 2023 | Crosstie |
| Acumed LLC | $123.00 | 2024 | Acumed |
| Stryker Corporation | $119.03 | 2023 | Easyfuse |
| Zimmer Biomet Holdings, INC. | $84.63 | 2019 | |
| Boston Scientific Corporation | $32.70 | 2019 | |
| Cardiovascular Systems INC. | $24.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Abbes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.